Sharps Technology is a publicly traded Solana (SOL) cryptocurrency treasury company. Originally a medical device company selling syringes and drug-delivery systems, Sharps pivoted in August 2025 when it raised ~$400M in a PIPE offering and deployed nearly all of it to purchase SOL. The legacy medical device business is residual and declining. Sharps now holds over 2,000,000 SOL, and its financial results are driven almost entirely by SOL price movements and staking yield. The company's model resembles a closed-end fund: Sharps issues equity to buy SOL, stakes up to 95% of its holdings with third-party validators to earn yield paid in SOL, and aims to trade at or above the per-share NAV of its SOL holdings. Staking rewards compound into additional SOL, growing the treasury over time. Sharps also has an ATM equity facility with ~$237M in capacity to issue shares and buy more SOL, and a $100M buyback program for when the stock trades at a discount to NAV. SOL holdings are custodied across BitGo, Anchorage Digital Bank, and Coinbase. Treasury management is overseen by Sol Edge Limited under a 20-year consulting agreement, for which Sharps paid a $10M upfront fee and will pay ~2% of assets annually going forward. The concept is similar to how MicroStrategy functions for Bitcoin, but with SOL as the underlying asset and staking yield as an additional return component.